CytoSorbents Research and Development Expense (% of Annual Revenues) Analysis

CytoSorbents Corp (CTSO)

0.8932 +0.05 (+6.54%) USD | NASDAQ | Dec 24, 16:00

0.8932 0.00 (0.00%) Pre-Market: 08:16

View Research and Development Expense (% of Annual Revenues) for CTSO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Research and Development Expense (% of Annual Revenues) Chart

Start Trial

View Historical Data

Start Trial

View R&D Expense Definition

Start Trial

R&D expense is a line item from many companies' income statements.

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Research and Development Expense (% of Annual Revenues) Benchmarks

Start Trial